Mather Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20
| Closed | -$5.42K | – | 644 |
|
|
2025
Q1 | $5.42K | Buy |
20
+8
| +67% | +$2.17K | ﹤0.01% | 1390 |
|
|
2024
Q4 | $2.82K | Buy |
12
+6
| +100% | +$1.41K | ﹤0.01% | 1479 |
|
|
2024
Q3 | $1.54K | Sell |
6
-4
| -40% | -$1.03K | ﹤0.01% | 1518 |
|
|
2024
Q2 | $1.49K | Buy |
10
+3
| +43% | +$448 | ﹤0.01% | 1951 |
|
|
2024
Q1 | $1.34K | Buy |
+7
| New | +$1.34K | ﹤0.01% | 1594 |
|